AMANDA GROOME: Open Payments
NPI 1013217850 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,349 in 90 payments from 15 companies in 2025. Trend: 2023 $2,799 · 2024 $1,572 · 2025 $2,349
Food & beverage: $2,240Education: $109
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $459 |
| Otsuka America Pharmaceutical, Inc. | 9 | $261 |
| E.R. Squibb & Sons, L.L.C. | 4 | $251 |
| Axsome Therapeutics, Inc. | 8 | $237 |
| Vanda Pharmaceuticals Inc. | 6 | $194 |
| Teva Pharmaceuticals USA, Inc. | 6 | $164 |
| Neurocrine BioSciences, Inc. | 10 | $160 |
| ABBVIE INC. | 16 | $155 |
| Alkermes, Inc. | 6 | $136 |
| Janssen Pharmaceuticals, Inc | 3 | $131 |
Products named: CAPLYTA, REXULTI, COBENFY, Auvelity, INGREZZA, VRAYLAR, SPRAVATO, FANAPT.
Industry payments across SC — which companies pay providers there.
